Branched-chain α-keto acid metabolism is controlled by SLC25A35-mediated mitochondrial import
In the authors' words
Liver is considered a primary site for systemic branched-chain alpha-keto acid (BCKA) oxidation due to its abundant dehydrogenase content. However, hepatocytes rely entirely on import of substrate generated elsewhere because they lack intrinsic branched-chain transaminase activity. The mechanisms governing BCKA transit into the mitochondrial matrix remain unknown. We found that mitochondrial import, rather than dehydrogenase activity, determines hepatocellular capacity for BCKA oxidation. We identified MCT1 and MCT2 as transporters required for cellular entry and SLC25A35 as the essential mitochondrial BCKA carrier. Crucially, hepatic SLC25A35 expression is low and limits the liver's contribution to systemic clearance. These findings establish the molecular machinery for BCKA transport and redefine the liver's role in BCKA homeostasis, revealing that mitochondrial transporter abundance, rather than dehydrogenase levels, dictates BCKA metabolic flux.
Appeared: Thursday, November 19. bioRxiv. Preprint, not yet peer-reviewed.